Sustained Release Ocular Drug Delivery Systems Market Report

Global and Region Sustained Release Ocular Drug Delivery Systems Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：208
  • REPORT CODE：GMM966526
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sustained Release Ocular Drug Delivery Systems market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sustained Release Ocular Drug Delivery Systemsmarket, defines the market attractiveness level of Sustained Release Ocular Drug Delivery Systems market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sustained Release Ocular Drug Delivery Systems industry, describes the types of Sustained Release Ocular Drug Delivery Systems market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sustained Release Ocular Drug Delivery Systems market and the development prospects and opportunities of Sustained Release Ocular Drug Delivery Systems industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sustained Release Ocular Drug Delivery Systems market in Chapter 13.

    By Player:

    • PolyActiva

    • Icon Bioscience

    • TheraKine

    • GrayBug

    • Innocore Pharmaceuticals

    • Neurotech Pharmaceuticals

    • OHR Pharmaceuticals

    • pSivida

    • Allergan

    • Envisia Therapeutics

    • Aciont Inc

    • Santen Pharmaceutical

    • Ocular Therapeutix

    By Type:

    • Liposome

    • Microcapsules/Nanocapsules

    • Microspheres/Nanosptheres

    • Implants

    By End-User:

    • Cataract

    • Glaucoma

    • Corneal Transplantation

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sustained Release Ocular Drug Delivery Systems Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sustained Release Ocular Drug Delivery Systems Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sustained Release Ocular Drug Delivery Systems Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sustained Release Ocular Drug Delivery Systems Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sustained Release Ocular Drug Delivery Systems Market Analysis and Outlook to 2022

    • 7.1 Global Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.2 United States Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.3 Europe Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.4 China Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.5 Japan Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.6 India Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    • 7.7 South Korea Sustained Release Ocular Drug Delivery Systems Consumption (2017-2022)

    8 Region and Country-wise Sustained Release Ocular Drug Delivery Systems Market Analysis and Outlook to 2028

    • 8.1 Global Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.2 United States Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.3 Europe Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.4 China Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.5 Japan Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.6 India Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    • 8.7 South Korea Sustained Release Ocular Drug Delivery Systems Consumption Forecast (2022-2028)

    9 Global Sustained Release Ocular Drug Delivery Systems Market Outlook by Types and Applications to 2022

    • 9.1 Global Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liposome Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Microcapsules/Nanocapsules Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Microspheres/Nanosptheres Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Implants Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cataract Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Glaucoma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Corneal Transplantation Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Sustained Release Ocular Drug Delivery Systems Market Outlook by Types and Applications to 2028

    • 10.1 Global Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liposome Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Microcapsules/Nanocapsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Microspheres/Nanosptheres Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Implants Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cataract Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Corneal Transplantation Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sustained Release Ocular Drug Delivery Systems Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sustained Release Ocular Drug Delivery Systems Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sustained Release Ocular Drug Delivery Systems Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sustained Release Ocular Drug Delivery Systems Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sustained Release Ocular Drug Delivery Systems Market Competitive Analysis

    • 14.1 PolyActiva

      • 14.1.1 PolyActiva Company Details

      • 14.1.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.2 Icon Bioscience

      • 14.2.1 Icon Bioscience Company Details

      • 14.2.2 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.3 TheraKine

      • 14.3.1 TheraKine Company Details

      • 14.3.2 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 TheraKine Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.4 GrayBug

      • 14.4.1 GrayBug Company Details

      • 14.4.2 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GrayBug Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.5 Innocore Pharmaceuticals

      • 14.5.1 Innocore Pharmaceuticals Company Details

      • 14.5.2 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.6 Neurotech Pharmaceuticals

      • 14.6.1 Neurotech Pharmaceuticals Company Details

      • 14.6.2 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.7 OHR Pharmaceuticals

      • 14.7.1 OHR Pharmaceuticals Company Details

      • 14.7.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.8 pSivida

      • 14.8.1 pSivida Company Details

      • 14.8.2 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 pSivida Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.9 Allergan

      • 14.9.1 Allergan Company Details

      • 14.9.2 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Allergan Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.10 Envisia Therapeutics

      • 14.10.1 Envisia Therapeutics Company Details

      • 14.10.2 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.11 Aciont Inc

      • 14.11.1 Aciont Inc Company Details

      • 14.11.2 Aciont Inc Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Aciont Inc Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.12 Santen Pharmaceutical

      • 14.12.1 Santen Pharmaceutical Company Details

      • 14.12.2 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product and Service

    • 14.13 Ocular Therapeutix

      • 14.13.1 Ocular Therapeutix Company Details

      • 14.13.2 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sustained Release Ocular Drug Delivery Systems

    • Figure Sustained Release Ocular Drug Delivery Systems Picture

    • Table Global Sustained Release Ocular Drug Delivery Systems Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sustained Release Ocular Drug Delivery Systems Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sustained Release Ocular Drug Delivery Systems Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sustained Release Ocular Drug Delivery Systems Consumption by Country (2017-2022)

    • Figure United States Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Table Europe Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure China Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Japan Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure India Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sustained Release Ocular Drug Delivery Systems Consumption and Growth Rate (2017-2022)

    • Figure Global Sustained Release Ocular Drug Delivery Systems Consumption Forecast by Country (2022-2028)

    • Figure United States Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sustained Release Ocular Drug Delivery Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposome Consumption and Growth Rate (2017-2022)

    • Figure Global Microcapsules/Nanocapsules Consumption and Growth Rate (2017-2022)

    • Figure Global Microspheres/Nanosptheres Consumption and Growth Rate (2017-2022)

    • Figure Global Implants Consumption and Growth Rate (2017-2022)

    • Figure Global Cataract Consumption and Growth Rate (2017-2022)

    • Figure Global Glaucoma Consumption and Growth Rate (2017-2022)

    • Figure Global Corneal Transplantation Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Liposome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microcapsules/Nanocapsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microspheres/Nanosptheres Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Implants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cataract Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corneal Transplantation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sustained Release Ocular Drug Delivery Systems Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sustained Release Ocular Drug Delivery Systems Export by Region (Top 5 Countries) (2017-2028)

    • Table PolyActiva (Foundation Year, Company Profile and etc.)

    • Table PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table PolyActiva Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Icon Bioscience (Foundation Year, Company Profile and etc.)

    • Table Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table TheraKine (Foundation Year, Company Profile and etc.)

    • Table TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table TheraKine Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table GrayBug (Foundation Year, Company Profile and etc.)

    • Table GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table GrayBug Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Innocore Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Neurotech Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table OHR Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table pSivida (Foundation Year, Company Profile and etc.)

    • Table pSivida Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table pSivida Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Envisia Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Aciont Inc (Foundation Year, Company Profile and etc.)

    • Table Aciont Inc Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aciont Inc Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Santen Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product and Service

    • Table Ocular Therapeutix (Foundation Year, Company Profile and etc.)

    • Table Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US